Eiko Lifesciences Balance Sheet Annual

BSE: - | NSE: - | ISIN: - | Sector: -

49.71 +0.55 (1.12%)Updated : 21 Jul 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	89.37	66.10	52.74	31.04
Cash Equivalents	13.61	11.78	13.35	0.61
Other Liabilities Total	0.00	0.00	-	-
Long Term Debt	3.06	2.01	0.00	0.00
Common Stock Total	14.35	13.76	12.87	8.32
Other Current Assets Total	9.60	4.54	1.06	0.68
Total Assets	89.37	66.10	52.74	31.04
Total Equity	68.78	56.79	50.68	29.42
Long Term Investments	15.29	7.15	4.02	1.18
Retained Earnings( Accumulated Deficit)	54.43	43.03	37.81	21.11
Total Common Shares Outstanding	1.37	1.39	1.39	0.96
Tangible Book Valueper Share Common Eq	50.13	40.97	36.56	30.66
Total Liabilities	20.59	9.31	2.06	1.62
Total Debt	4.73	2.76	0.00	0.05
Cashand Short Term Investments	13.61	11.78	13.35	0.61
Total Receivables Net	20.22	10.79	13.13	7.11
Notes Payable/ Short Term Debt	1.67	0.76	0.00	0.00
Deferred Income Tax	1.11	0.82	0.56	0.42
Accounts Receivable- Trade Net	20.22	10.79	13.13	7.11
Property/ Plant/ Equipment Total- Net	22.10	23.12	13.57	13.88
Minority Interest	1.05	0.22	-	-
Total Current Liabilities	15.38	6.27	1.50	1.20
Total Inventory	3.97	5.77	3.39	0.91
Accounts Payable	12.56	3.31	1.38	1.05
Other Currentliabilities Total	1.15	2.20	0.12	0.10
Total Long Term Debt	3.06	2.01	0.00	0.00
Other Long Term Assets Total	0.00	0.00	0.00	-
Note Receivable- Long Term	4.57	2.95	4.23	6.68
period Length	0.00	0.00	0.00	0.00
Total Current Assets	47.41	32.88	30.93	9.30
Current Portof LT Debt/ Capital Leases	-	-	0.00	0.05